A genome wide linkage search for breast cancer susceptibility genes
Mutations in known breast cancer susceptibility genes account for a minority of the familial aggregation of the disease. To search for further breast cancer susceptibility genes, we performed a combined analysis of four genome‐wide linkage screens, which included a total of 149 multiple case breast...
Saved in:
Published in: | Genes chromosomes & cancer Vol. 45; no. 7; pp. 646 - 655 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-07-2006
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mutations in known breast cancer susceptibility genes account for a minority of the familial aggregation of the disease. To search for further breast cancer susceptibility genes, we performed a combined analysis of four genome‐wide linkage screens, which included a total of 149 multiple case breast cancer families. All families included at least three cases of breast cancer diagnosed below age 60 years, at least one of whom had been tested and found not to carry a BRCA1 or BRCA2 mutation. Evidence for linkage was assessed using parametric linkage analysis, assuming both a dominant and a recessive mode of inheritance, and using nonparametric methods. The highest LOD score obtained in any analysis of the combined data was 1.80 under the dominant model, in a region on chromosome 4 close to marker D4S392. Three further LOD scores over 1 were identified in the parametric analyses and two in the nonparametric analyses. A maximum LOD score of 2.40 was found on chromosome arm 2p in families with four or more cases of breast cancer diagnosed below age 50 years. The number of linkage peaks did not differ from the number expected by chance. These results suggest regions that may harbor novel breast cancer susceptibility genes. They also indicate that no single gene is likely to account for a large fraction of the familial aggregation of breast cancer that is not due to mutations in BRCA1 or BRCA2. © 2006 Wiley‐Liss, Inc. |
---|---|
Bibliography: | National Cancer Institute - No. RFA #CA-95-003 Cancer Research UK Cancer Council of New South Wales istex:D04EE4E9DE5B6D376F5CB6DB30FD14EE47E9834B Cancer Council of Victoria Victorian Health Promotion Foundation Cancer Council of Tasmania NSW Cancer Council Kathleen Cuningham Foundation Queensland Cancer Fund National Breast Cancer Foundation Cancer Council of South Australia Breast Cancer Research Foundation (BCRF) Dutch Cancer Society - No. RUL1999-2021 ark:/67375/WNG-Q4T9NG3X-V Canadian Institute of Health Research (INHERIT program) National Health and Medical Research Council (NHMRC) ArticleID:GCC20330 Cancer Foundation of Western Australia ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1045-2257 1098-2264 |
DOI: | 10.1002/gcc.20330 |